Small-molecule inhibitor targeting p38γ (MAPK12) to prevent tau phosphorylation at Ser396/404, reducing neurofibrillary tangle formation. Strong mechanistic data but challenged by kinase selectivity barriers, p38 inhibitor class failures in prior AD trials, and high development costs.
AAV9-mediated overexpression of LAMP2A enhances chaperone-mediated autophagy to selectively degrade pathological alpha-synuclein species, preventing Lewy body formation and blocking cell-to-cell propagation. Strongest mechanistic foundation with validated AAV platform and clear patient stratification via seed amplification assays.
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
AutophagyUnspecified Mechanismneurodegeneration
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
1/11
dimensions won
Selective p38γ MAPK Inhibition Reduces P
11/11
dimensions won
LAMP2A-Mediated Autophagy Enhancement Bl
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.70
0.80
Evidence
0.65
0.75
Novelty
0.60
0.70
Feasibility
0.55
0.75
Impact
0.70
0.80
Druggability
0.50
0.70
Safety
0.50
0.65
Competition
0.60
0.75
Data
0.75
0.80
Reproducible
0.70
0.75
KG Connect
0.50
0.50
Score Breakdown
Dimension
Selective p38γ MAPK Inhibition
LAMP2A-Mediated Autophagy Enha
Mechanistic
0.700
0.800
Evidence
0.650
0.750
Novelty
0.600
0.700
Feasibility
0.550
0.750
Impact
0.700
0.800
Druggability
0.500
0.700
Safety
0.500
0.650
Competition
0.600
0.750
Data
0.750
0.800
Reproducible
0.700
0.750
KG Connect
0.500
0.500
Evidence
Selective p38γ MAPK Inhibition Reduces Pathological Tau Phos